World Kinect director granted 7,070 RSU shares
BAKSHI KEN reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BAKSHI KEN reported acquisition or exercise transactions in this Form 4 filing.
WORLD KINECT CORP director Ken Bakshi received a stock-based compensation award, not an open‑market purchase. He was granted 7,070 shares of common stock as a restricted stock unit grant at a stated price of $0.00 per share. Following this award, he directly holds 59,306 shares of common stock. The restricted stock units will vest on the earlier of the day before the next annual shareholder meeting after the grant date or the one‑year anniversary of the grant date, tying the award to a roughly one‑year service period.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,070 | $0.00 | $0.00 |
Footnotes (2)
- F1. These shares were issued as a restricted stock unit grant to the reporting person by the issuer.
- F2. The restricted stock units shall vest on the earlier of (i) the day prior to the annual meeting of the shareholders of the issuer that next follows the grant date or (ii) the one-year anniversary of the grant date.
Key Figures
Key Terms
restricted stock unit financial
vest financial
grant date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did WORLD KINECT CORP (WKC) report for Ken Bakshi?
When do Ken Bakshi’s new restricted stock units in WORLD KINECT CORP (WKC) vest?
What does the $0.00 price on Ken Bakshi’s WORLD KINECT CORP (WKC) grant mean?
AI-generated analysis. How Rhea-AI works. Not financial advice.